ketoconazole has been researched along with thiabendazole in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Dai, JK; Dan, WJ; Wan, JB | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Sharp, NJ; Sullivan, M | 1 |
| Gugnani, HC; Okeke, CN | 1 |
| Drachman, D; Zaias, N | 1 |
| Engelen, M; Rochette, F; Vanden Bossche, H | 1 |
3 review(s) available for ketoconazole and thiabendazole
| Article | Year |
|---|---|
Natural and synthetic β-carboline as a privileged antifungal scaffolds.
Topics: Animals; Antifungal Agents; Biological Products; Carbolines; Drug Discovery; Female; Humans; Male; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycoses; Protein Binding; Signal Transduction; Structure-Activity Relationship | 2022 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antifungal agents of use in animal health--chemical, biochemical and pharmacological aspects.
Topics: Animals; Antifungal Agents; Clotrimazole; Drug Resistance, Fungal; Econazole; Fluconazole; Flucytosine; Griseofulvin; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Natamycin; Nystatin; Terbinafine; Thiabendazole; Tolnaftate; Veterinary Drugs | 2003 |
1 trial(s) available for ketoconazole and thiabendazole
| Article | Year |
|---|---|
A method for the determination of drug effectiveness in onychomycosis. Trials with ketoconazole and griseofulvin ultramicrosize.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Foot Dermatoses; Griseofulvin; Humans; Ketoconazole; Male; Middle Aged; Nails; Onychomycosis; Thiabendazole | 1983 |
5 other study(ies) available for ketoconazole and thiabendazole
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Use of ketoconazole in the treatment of canine nasal aspergillosis.
Topics: Animals; Aspergillosis; Aspergillus fumigatus; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Ketoconazole; Nose Diseases; Thiabendazole | 1989 |
In vitro sensitivity of environmental isolates of pathogenic dematiaceous fungi to azole compounds and a phenylpropyl-morpholine derivative.
Topics: Animals; Antifungal Agents; Culture Media; Econazole; Fungi; Imidazoles; Ketoconazole; Mice; Miconazole; Microbial Sensitivity Tests; Morpholines; Thiabendazole; Triazoles | 1987 |